News Dutch GPs warned against new contraceptive pill BMJ 2002; 324 doi: https://doi.org/10.1136/bmj.324.7342.869 (Published 13 April 2002) Cite this as: BMJ 2002;324:869 Article Related content Metrics Responses Peer review Related articles Research The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study Published: 13 August 2009; BMJ 339 doi:10.1136/bmj.b2921 Research Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database Published: 21 April 2011; BMJ 342 doi:10.1136/bmj.d2139 Cited by... Comparative risks of venous thromboembolism among users of oral contraceptives containing drospirenone and levonorgestrelFulltext PDF Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research DatabaseFulltext PDF Abstract The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control studyFulltext PDF Abstract Venous Thrombosis: The Role of Genes, Environment, and BehaviorFulltext PDF Abstract Drug points: Thromboembolism associated with the new contraceptive YasminFulltext PDF Abstract Is {blacktriangledown}Yasmin a "truly different" pill?Fulltext PDF Abstract
